Skip to content

Filana Therapeutics, Inc.: filings

Every Filana Therapeutics, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 60 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-05-07fiscal Q1 202626540001437749-26-015664
10-K2026-03-12fiscal FY 202535890001437749-26-007962
10-Q2025-11-12fiscal Q3 202531960001437749-25-034427
10-Q2025-08-14fiscal Q2 202531920001437749-25-026686
10-Q2025-05-08fiscal Q1 202531640001437749-25-015478
10-K2025-03-03fiscal FY 202437940001437749-25-005919
10-Q2024-11-07fiscal Q3 2024351070001437749-24-033944
10-Q2024-08-08fiscal Q2 202432970001437749-24-025611
10-Q2024-05-10fiscal Q1 202433680001437749-24-016040
10-K2024-02-28fiscal FY 202336920001437749-24-005894
10-Q2023-11-07fiscal Q3 2023341020001437749-23-030502
10-Q2023-08-03fiscal Q2 2023381080001069530-23-000039
10-Q2023-05-01fiscal Q1 202336750001069530-23-000017
10-K2023-02-28fiscal FY 202238930001069530-23-000009
10-Q2022-11-07fiscal Q3 2022371020001069530-22-000058
10-Q2022-08-04fiscal Q2 202237940001069530-22-000033
10-Q2022-05-05fiscal Q1 202237690001069530-22-000023
10-K2022-03-01fiscal FY 202138720001069530-22-000011
10-Q2021-11-15fiscal Q3 202137980001069530-21-000050
10-Q2021-08-04fiscal Q2 202132820001069530-21-000045
10-Q2021-04-29fiscal Q1 202128570001069530-21-000027
10-K2021-03-23fiscal FY 202027560001069530-21-000020
10-Q2020-11-09fiscal Q3 202030840001069530-20-000066
10-Q2020-08-12fiscal Q2 202028750001069530-20-000045
10-Q2020-05-06fiscal Q1 202026570001069530-20-000032
10-K2020-03-26fiscal FY 201928510001069530-20-000009
10-Q2019-10-29fiscal Q3 201928770001069530-19-000036
10-Q2019-08-12fiscal Q2 201928750001069530-19-000032
10-Q2019-05-02fiscal Q1 201928580001069530-19-000026
10-K2019-03-29fiscal FY 201825490001069530-19-000019
10-Q2018-10-30fiscal Q3 201826600001069530-18-000060
10-Q2018-07-26fiscal Q2 201827640001069530-18-000031
10-Q2018-05-09fiscal Q1 201827530001069530-18-000023
10-K2018-02-06fiscal FY 201726520001069530-18-000004
10-Q2017-11-01fiscal Q3 201724590001069530-17-000036
10-Q2017-08-09fiscal Q2 201723600001069530-17-000032
10-Q2017-04-26fiscal Q1 201722460001069530-17-000024
10-K2017-03-07fiscal FY 201624710001069530-17-000008
10-Q2016-10-26fiscal Q3 201625630001069530-16-000065
10-Q2016-07-19fiscal Q2 201622570001069530-16-000063
10-Q2016-05-05fiscal Q1 201622450001069530-16-000057
10-K2016-03-03fiscal FY 201531970001069530-16-000052
10-Q2015-11-09fiscal Q3 201524630001069530-15-000030
10-Q2015-07-23fiscal Q2 201523610001069530-15-000026
10-Q2015-05-08fiscal Q1 201523470001069530-15-000012
10-K2015-02-18fiscal FY 201430940001069530-15-000003
10-Q2014-11-05fiscal Q3 201423560001069530-14-000032
10-Q2014-08-06fiscal Q2 201423550001069530-14-000025
10-Q2014-05-07fiscal Q1 201422430001069530-14-000018
10-K2014-02-05fiscal FY 201330930001069530-14-000004
10-Q2013-11-01fiscal Q3 201324610001069530-13-000005
10-Q2013-08-01fiscal Q2 201324610001193125-13-315094
10-Q2013-04-24fiscal Q1 201326510001193125-13-170549
10-K2013-02-08fiscal FY 201232860001193125-13-046147
10-Q2012-11-09fiscal Q3 201226640001193125-12-461190
10-Q2012-08-02fiscal Q2 201226650001193125-12-331983
10-Q2012-05-08fiscal Q1 201227540001193125-12-218890
10-K2012-02-09fiscal FY 201130780001193125-12-049361
10-Q2011-11-03fiscal Q3 201125610001193125-11-294207
10-Q2011-08-04fiscal Q2 201125610001193125-11-210394

Inspect the source

Entity
Filana Therapeutics, Inc. / CIK 0001069530
Captured
2026-09-20T05:19:22.728Z
SEC response SHA-256
98fbf2ec9e4273c7c7ff1d5342c79c5958c86b1e088e060391ccaf7c9ba8ef57

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001069530.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))